Nutex Health (NASDAQ:NUTX) Price Target Raised to $357.00

Nutex Health (NASDAQ:NUTX) had its price objective raised by B. Riley Financial from $325.00 to $357.00 in a research report released on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock.

NUTX has been the subject of a number of other research reports. Zacks Research downgraded Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Ladenburg Thalmann & Co. Inc. began coverage on shares of Nutex Health in a report on Monday, October 26th. They issued a “buy” rating and a $336.00 price target on the stock. Wall Street Zen lowered shares of Nutex Health from a “buy” rating to a “hold” rating in a research report on Saturday, October 31st. Weiss Ratings raised shares of Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Finally, Lake Street Capital restated a “buy” rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $342.00.

Nutex Health Stock Up 1.6%

NUTX opened at $189.19 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 4.76. The business has a 50 day moving average price of $203.19 and a 200 day moving average price of $151.91. The firm has a market cap of $1.30 billion, a P/E ratio of 7.95 and a beta of 0.66. Nutex Health has a twelve month low of $83.99 and a twelve month high of $226.16.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Thursday, November 5th. The company reported $5.71 EPS for the quarter, topping the consensus estimate of $5.54 by $0.17. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. The firm had revenue of $217.61 million for the quarter, compared to the consensus estimate of $214.82 million. Research analysts forecast that Nutex Health will post 27.70 EPS for the current year.

Insider Activity at Nutex Health

In other news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director owned 400 shares in the company, valued at $85,700. The trade was a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 44.68% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Nutex Health during the 2nd quarter worth about $69,612,000. Winmill & CO. Inc. acquired a new position in Nutex Health during the 2nd quarter valued at about $11,168,000. Empowered Funds LLC bought a new position in shares of Nutex Health in the 2nd quarter valued at about $7,720,000. Bank of New York Mellon Corp bought a new position in shares of Nutex Health in the 2nd quarter valued at about $3,956,000. Finally, Bridge City Capital LLC bought a new position in shares of Nutex Health in the 3rd quarter valued at about $3,918,000. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.